Compare Stocks → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:GVNASDAQ:METXNYSE:REEDNASDAQ:RKDA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGVVisionary$0.27+8.0%$0.18$0.10▼$0.74$10.60M1.73244,554 shs585,742 shsMETXBTC Digital$2.41+4.3%$3.14$1.75▼$9.93$1.37M0.0733,951 shs4,041 shsREEDReed's$1.33-0.7%$1.63$1.21▼$3.75$5.52M1.116,291 shs623 shsRKDAArcadia Biosciences$1.96-1.5%$2.27$1.85▼$7.30$2.66M0.6217,184 shs9,288 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGVVisionary-1.46%+80.36%+76.24%+50.92%+26,999,900.00%METXBTC Digital+4.33%-8.02%-31.14%-37.08%-36.55%REEDReed's0.00%-8.62%-17.54%-32.74%-47.00%RKDAArcadia Biosciences+0.77%-6.46%-6.46%-23.03%-66.41%Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGVVisionaryN/AN/AN/AN/AN/AN/AN/AN/AMETXBTC DigitalN/AN/AN/AN/AN/AN/AN/AN/AREEDReed's2.0172 of 5 stars3.50.00.00.01.72.50.6RKDAArcadia Biosciences1.4536 of 5 stars3.53.00.00.01.50.00.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGVVisionaryN/AN/AN/AN/AMETXBTC DigitalN/AN/AN/AN/AREEDReed's3.00Buy$7.00428.30% UpsideRKDAArcadia Biosciences3.00Buy$10.00411.51% UpsideCurrent Analyst RatingsLatest GV, METX, REED, and RKDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/5/2024RKDAArcadia BiosciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGVVisionary$8.43M1.26N/AN/A$0.32 per share0.84METXBTC Digital$81.60M0.02$10.48 per share0.23$33.81 per share0.07REEDReed's$44.71M0.12N/AN/A($4.62) per share-0.29RKDAArcadia Biosciences$5.33M0.50N/AN/A$11.44 per share0.17Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGVVisionary-$3.47MN/A0.00∞N/AN/AN/AN/A8/20/2024 (Estimated)METXBTC Digital$7.69MN/A0.00∞N/AN/AN/AN/AN/AREEDReed's-$15.52M-$5.10N/AN/AN/A-34.72%N/A-59.13%5/30/2024 (Estimated)RKDAArcadia Biosciences-$13.98M-$14.24N/A∞N/A-246.80%-81.56%-50.80%5/9/2024 (Confirmed)Latest GV, METX, REED, and RKDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2024N/ARKDAArcadia Biosciences-$2.52N/A+$2.52N/AN/AN/A 3/28/2024Q4 2023REEDReed's-$0.31-$1.25-$0.94-$0.43$14.08 million$11.69 million3/28/2024Q4 2023RKDAArcadia Biosciences-$2.68-$2.48+$0.20-$2.86$1.80 million$1.17 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGVVisionaryN/AN/AN/AN/AN/AMETXBTC DigitalN/AN/AN/AN/AN/AREEDReed'sN/AN/AN/AN/AN/ARKDAArcadia BiosciencesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGVVisionary0.040.26N/AMETXBTC DigitalN/A1.271.27REEDReed'sN/A0.650.24RKDAArcadia BiosciencesN/A4.173.63OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGVVisionary0.70%METXBTC Digital0.46%REEDReed's51.48%RKDAArcadia Biosciences17.73%Insider OwnershipCompanyInsider OwnershipGVVisionary9.22%METXBTC Digital6.84%REEDReed's46.70%RKDAArcadia Biosciences2.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableGVVisionary3039.25 million35.63 millionNot OptionableMETXBTC Digital16570,000531,000Not OptionableREEDReed's214.17 million2.22 millionNot OptionableRKDAArcadia Biosciences211.36 million1.34 millionNot OptionableGV, METX, REED, and RKDA HeadlinesSourceHeadlineArcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Releasezacks.com - May 2 at 11:05 AMArcadia Biosciences (RKDA) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - May 2 at 3:50 AMArcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.comamericanbankingnews.com - April 29 at 2:26 AMArcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Callbusinesswire.com - April 25 at 8:02 AMNew Strong Sell Stocks for April 22ndzacks.com - April 22 at 7:46 AMSNDL, Arcadia Biosciences among Consumer Staples moversmsn.com - April 17 at 12:57 PMBuy Rating on Arcadia Biosciences Fueled by Strategic Initiatives and Innovative Product Launchesmarkets.businessinsider.com - April 6 at 1:44 PMBuy Rating Affirmed for Arcadia Biosciences Amidst Growth and Strategic Shiftsmarkets.businessinsider.com - April 1 at 10:29 PMMicrosoft unbundles Teams and Office 365 for customers worldwidesg.news.yahoo.com - April 1 at 5:29 PMArcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Yzacks.com - April 1 at 12:26 PMArcadia Biosciences Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - April 1 at 12:25 PMArcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 12:25 PMArcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 3:21 PMQ4 2023 Arcadia Biosciences Inc Earnings Callfinance.yahoo.com - March 29 at 2:29 PMArcadia Biosciences: Q4 Earnings Snapshotsfgate.com - March 28 at 11:01 PMRKDA Stock Earnings: Arcadia Biosciences Beats EPS, Misses Revenue for Q4 2023msn.com - March 28 at 11:01 PMArcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimateszacks.com - March 28 at 8:26 PMRecap: Arcadia Biosciences Q4 Earningsbenzinga.com - March 28 at 5:57 PMArcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlightsbusinesswire.com - March 28 at 4:05 PMArcadia Biosciences, Inc. (RKDA)finance.yahoo.com - March 23 at 5:59 PMArcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Callfinance.yahoo.com - March 14 at 11:30 AMArcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availabilityfinance.yahoo.com - February 20 at 9:43 AMArcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availabilitybusinesswire.com - February 20 at 8:02 AMHYFM Sep 2024 1.000 callca.finance.yahoo.com - February 16 at 11:31 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsVisionaryNASDAQ:GVVisionary Holdings Inc. provides private online and in person educational programs and services to Canadian and international students that reside in Canada and internationally. The company's educational programs include Ontario secondary school diploma, career-oriented two-year college and four-year university diploma programs, vocational education programs, and master programs. It also provides educational services, such as immigration and study visa, student housing, career guidance, internship, and entrepreneurship guidance. The company was formerly known as Visionary Education Technology Holdings Group Inc. and changed its name to Visionary Holdings Inc. in February 2024. The company was incorporated in 2013 and is headquartered in Toronto, Canada. Visionary Holdings Inc. operates as a subsidiary of 3888 Investment Group Limited.BTC DigitalNASDAQ:METXBTC Digital Ltd. engages in the cryptocurrency/bitcoin mining business. It also engages in mining machines resale and rental business. The company was formerly known as Meten Holding Group Ltd. and changed its name to BTC Digital Ltd. in August 2023. The company was founded in 2006 and is headquartered in Shenzhen, the People's Republic of China.Reed'sNYSE:REEDReed's, Inc. engages in the manufacture and distribution of natural beverages in the United States. The company offers Reed's craft ginger beer; Reed's real ginger ales; Reed's Classic Mules; Reed's Hard Ginger Ale; Reed's ready to drink products; and Virgil's handcrafted sodas. It sells its products to natural food and gourmet retailers, grocery store chains, mass merchants, club stores, convenience and drug stores, liquor stores, industrial cafeterias, and on-premise bars and restaurants, as well as directly to consumers through www.drinkreeds.com. The company was formerly known as Original Beverage Corporation and changed its name to Reed's, Inc. in 2001. Reed's, Inc. was founded in 1987 and is headquartered in Norwalk, Connecticut.Arcadia BiosciencesNASDAQ:RKDAArcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
